Abstract
The present invention relates to use of small organic compounds interacting with the Voltage-Dependent Anion Channel (VDAC) for the treatment of diseases associated with central nervous system (CNS) disorders, including psychotic disorders, mood disorders, neurodegenerative diseases. In particular the present invention relates to the use of substituted piperazine- and piperidine-derivatives and pharmaceutical compositions comprising same for the treatment of psychotic disorders including schizophrenia, mood disorders, and neurodegenerative diseases.
| Original language | English |
|---|---|
| Patent number | US2020000801 |
| IPC | A61K 31/ 495 A I |
| Priority date | 4/09/19 |
| State | Published - 2 Jan 2020 |